Apr 07, 2022 / Presentations

Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts

Research Areas:

Drugs, Devices, and Tests

Apr 07, 2022 / Transcripts

April 2022 meeting transcript

Research Areas:

Ambulatory Care Settings, Drugs, Devices, and Tests, Medicare Spending and Financing, Quality

Mar 15, 2022 / Press Releases

MedPAC releases March 2022 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2022 / Reports

March 2022 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2022 / Chapters

Executive Summary (March 2022 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 15, 2022 / Chapters

Chapter 13: The Medicare prescription drug program (Part D): Status report (March 2022 Report)

Research Areas:

Drugs, Devices, and Tests, Quality

Mar 15, 2022 / Chapters

Appendix A: Commissioners’ voting on recommendations (March 2022 Report)

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Mar 04, 2022 / Comment Letters

MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D

Research Areas:

Drugs, Devices, and Tests, Private Plans

Mar 03, 2022 / Presentations

Medicare payment policies to support safety-net providers

Research Areas:

Hospitals

Feb 02, 2022 / Congressional Testimony

Testimony: The Hospital Insurance Trust Fund and the Future of Medicare Financing (Senate Finance)

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans, Quality